Literature DB >> 16828835

HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.

Anjana Yadav1, Shibani Pati, Anhthu Nyugen, Oxana Barabitskaja, Prosanta Mondal, Michael Anderson, Robert C Gallo, David L Huso, William Reid.   

Abstract

Impaired CD4+ T cell responses, resulting in dysregulated T-helper 1 (Th1) effector and memory responses, are a common result of HIV-1 infection. These defects are often preceded by decreased expression and function of the alpha/beta T cell receptor (TCR)-CD3 complex and of co-stimulatory molecules including CD28, resulting in altered T cell proliferation, cytokine secretion and cell survival. We have previously shown that HIV Tg rats have defective development of T cell effector function and generation of specific effector/memory T cell subsets. Here we identify abnormalities in activated HIV-1 Tg rat CD4+ T cells that include decreased pY505 dephosphorylation of Lck (required for Lck activation), decreased CD28 function, reduced expression of the anti-apoptotic molecule Bcl-xL, decreased secretion of the mitogenic lympokine interleukin-2 (IL-2) and increased activation induced apoptosis. These events likely lead to defects in antigen-specific signaling and may help explain the disruption of Th1 responses and the generation of specific effector/memory subsets in transgenic CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828835     DOI: 10.1016/j.virol.2006.05.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.

Authors:  Brenda De Keersmaecker; Sabine D Allard; Patrick Lacor; Rik Schots; Kris Thielemans; Joeri L Aerts
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

2.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

Review 3.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

4.  Activation of Notch signaling pathway in HIV-associated nephropathy.

Authors:  Madhulika Sharma; Shannon Callen; Da Zhang; Pravin C Singhal; Gregory B Vanden Heuvel; Shilpa Buch
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

5.  Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease.

Authors:  Anjana Yadav; Phillip Fitzgerald; Mohammad M Sajadi; Bruce Gilliam; Mark K Lafferty; Robert Redfield; William Reid
Journal:  Virology       Date:  2009-01-09       Impact factor: 3.616

Review 6.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

7.  Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats.

Authors:  Mark K Lafferty; Lori Fantry; Joseph Bryant; Odell Jones; Dima Hammoud; M Neale Weitzmann; George K Lewis; Alfredo Garzino-Demo; William Reid
Journal:  Pathog Dis       Date:  2014-01-10       Impact factor: 3.166

8.  Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats.

Authors:  Caroline R Clary; Daniel M Guidot; Margaux A Bratina; Jeffrey S Otis
Journal:  AIDS Res Ther       Date:  2011-08-16       Impact factor: 2.250

9.  HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging.

Authors:  Susan J Abbondanzo; Sulie L Chang
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.